RT @JulianDownward: In our new paper just out in Science Advances we investigate mechanisms that may be limiting responses of KRAS mutant l…

RT @TheCrick: "Lung cancer is one of the hardest types of cancer to treat, so working out how to harness the immune system to better target…

The team 💪🏻 Megan Cole @Anastap78 @ClaudiaLee_ @fey980860 @andrea_dcg, @JhRoelink, Moore, @EdurMugarza Martin Jones @Karishma_Valand @ColliverEmma @SareenaRana @MihaelaAngel0va @EnfieldKatey @AEJMagness @gavinpaulkelly @TGruijl @molina_arcas @CharlesSwanton @JulianDownward

@TheCrick @Anastap78 @molina_arcas @andrea_dcg @ColliverEmma @SareenaRana @JulianDownward Do you want to know what the paper is about? Tonight at 19:00 CET it will be published, so watch this space!

SPACETIME brings together brilliant minds from Europe to spatiotemporally map the complex tumour-host coevolution in lung cancer, with the aim to understand how mechanisms of immune suppression develop and how these can be targeted therapeutically. #WorldLungCancerDay2024

RT @SPACETIME_EU: SPACETIME project starts today! 15 partners from 7 different European countries will work on spatially decoding lung canc…

@obrien_nd Yes you can, but competition will be fierce. There will also be two techician positions coming up soon, in case that might of of interest.

RT @immunometlab: Our @ScienceLab_MCBI department is #hiring 3 #PhD students to study the lung cancer tumor microenvironment in the context…

These observations mimic the results in mice and strongly suggest a role for these communities even beyond the context of KRAS inhibitors.